Every 10-Q that Harte Hanks (HHS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HHS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HHS filings page.
Harte Hanks, Inc. reported weaker results for the quarter and six months ended June 30, 2026 and disclosed a pending sale to Star Equity Holdings. Quarterly revenue was $37.98 million, down 1.7% year over year, and the company posted an operating loss of $4.49 million versus near break-even in 2025. Net loss widened to $5.00 million (basic and diluted EPS $(0.67)) from a loss of $0.34 million (EPS $(0.05)). For the first half of 2026, revenue declined 6.2% to $75.25 million, with an operating loss of $5.26 million compared with essentially break-even a year earlier; net loss increased to $5.63 million (EPS $(0.76)) from $0.73 million.
Cash and restricted cash were $5.19 million, and Harte Hanks used $2.65 million in operating cash in the first half, an improvement from $5.67 million used a year earlier. The company had $3.0 million drawn on its $25.0 million asset-based revolving credit facility and available borrowing capacity of $21.3 million. Total stockholders’ equity declined to $15.35 million from $20.53 million at year-end 2025.
Subsequent to quarter end, Harte Hanks entered into a merger agreement under which Star Equity agreed to acquire all outstanding shares in a stock-and-cash transaction. Each Harte Hanks share will be converted into the right to receive $5.00 in cash or equivalent Star Equity preferred stock, subject to a 50% cap on aggregate cash consideration. The estimated total consideration is approximately 1.92 million preferred shares and $19.2 million in cash, with closing targeted for the fourth quarter of 2026, subject to stockholder approval and other conditions.
Harte Hanks, Inc. reported softer results for the quarter ended March 31, 2026. Revenue was $37.3 million, down 10.3% from $41.6 million, driven mainly by a 16.6% decline in Fulfillment & Logistics and a 9.9% drop in Revenue Solutions, while Customer Care slipped 1.1%.
Operating expenses fell 8.6% to $38.0 million, but the company still posted an operating loss of $0.8 million versus a near breakeven loss a year earlier. Net loss widened to $0.6 million, or $(0.08) per share, compared with a $(0.05) loss.
Harte Hanks continued its "Project Elevate" restructuring, recording $0.2 million of charges in the quarter and $10.0 million cumulatively through March 31, 2026. Cash and restricted cash totaled $4.5 million, with no borrowings and $24.3 million available under its revolving credit facility, supporting liquidity despite modest cash use in operations.
Harte Hanks (HHS) filed its Q3 2025 10‑Q, showing softer demand across all segments and a swing to loss. Revenue was $39.5M (down 17% year over year) with operating income of $0.5M versus $1.9M a year ago. After other expenses of $0.2M and income tax expense of $2.6M, the company reported a net loss of $2.3M (basic and diluted EPS $(0.31)).
By segment in Q3: Marketing Services $8.8M and Customer Care $11.6M declined on customer turnover and program timing, while Fulfillment & Logistics $19.1M delivered stronger profitability, lifting segment operating income to $1.7M from $1.1M last year. Year to date, revenue was $119.7M (down 13.3%) and operating income was $0.5M.
Cash and equivalents were $6.5M at September 30, 2025; net cash used in operating activities was $2.5M year to date. The company extended its $25.0M revolving credit facility to June 30, 2028 at SOFR + 2.25%, had $1.0M in letters of credit outstanding, and no borrowings, leaving $24.0M available capacity. Project Elevate restructuring costs were $0.5M in Q3 and $1.5M year to date; total targeted reorganization savings across 2024–2026 are $16.0M. Shares outstanding were 7,414,794 as of October 31, 2025.
Harte Hanks reported lower revenue and a small net loss for the quarter ended June 30, 2025.
Revenue fell to $38.6 million for the quarter (down 14.2% year-over-year) and $80.2 million for the six months (down 11.4%). The company recorded a net loss of $0.3 million for the quarter and $0.7 million for six months, equal to basic and diluted losses per share of $0.05 and $0.10, respectively. Cash and cash equivalents declined to $4.8 million at June 30, 2025. Operating expenses declined year-over-year (11.6% for the quarter; 9.6% for six months) as the company reduced labor and other costs and continued its transformation program, Project Elevate, which targets $16.0 million of cumulative savings. The company extended its asset-based revolving Credit Facility to June 30, 2028 and had $24.0 million of borrowing availability after letters of credit.